TheProfitWatch

ACHV - Achieve Life Sciences, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.15 -0.01 (-0.31%) --- --- 0.0 (-0.01%) 0.05 (1.59%) 0.0 (0.16%) -0.07 (-2.17%) -0.07 (-2.17%)

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Category: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.37
Diluted EPS:
-0.37
Basic P/E:
-8.4868
Diluted P/E:
-8.4868
RSI(14) 1m:
0.0
VWAP:
3.14
RVol:
0.4229

Events

Period Kind Movement Occurred At
1m Price increase 1m 3.24 +0.04 (+1.25%) Oct 15 09:31

Related News